Those who have been diagnosed with type 2 diabetes receive better care when they are treated by a multidisciplinary collaborative care team, a study revealed. These findings were reported by the National University of Singapore, which conducted a six-month trial with patients selected from four health institutions. These patients were over 21 years old and had been diagnosed with polypharmacy, comorbidities, and uncontrolled type 2 diabetes. A total of 411 patients were placed in the study.
One group of patients served as the control team and continued their healthcare as normal. The other group received additional care from their pharmacist. In total, those receiving multidisciplinary collaborative care saw an improvement on their A1c. Pre-trial A1c averaged 8.6 with a deviation of 1.5%, while post-trial A1c averages showed 8.1 with a deviation of 1.3%. Those with higher A1c levels showed up to a 0.8% improvement. Individuals in the control group had no significant A1c changes.
These findings were published in Journal of Clinical Pharmacy and Therapeutics on April 27, 2017.